Department of Hepatobiliary-Pancreatic Surgery, China-Japan Union Hospital of Jilin University, Changchun, Jilin Province, China.
Eur J Gastroenterol Hepatol. 2024 Dec 1;36(12):1464-1469. doi: 10.1097/MEG.0000000000002866. Epub 2024 Oct 30.
The albumin-bilirubin (ALBI) and ΔALBI grades have attracted substantial attention for their ability to predict the overall survival (OS) of patients with hepatocellular carcinoma (HCC). This retrospective study aimed to evaluate the predictive value of the ALBI grade at different time points for the OS of patients with HCC who underwent surgical resection.
The clinical data of patients with HCC who underwent radical resection in our hospital were collected and analyzed. The survival rate was analyzed using the Kaplan-Meier method and log-rank test. The risk factors influencing OS were identified via univariate and multivariate Cox regression analyses.
A total of 104 patients with HCC were included in this study. The 1-, 3-, and 5-year OS rates of these patients were 91.3%, 64.0%, and 60.2%, respectively. The OS rates were significantly higher in patients with early-stage postoperative ALBI grade 2 than in those with grade 3 (P < 0.001); however, the preoperative ALBI grade, later-stage postoperative ALBI grade, ΔALBI grade (early stage), or ΔALBI grade (later stage) did not affect the OS rate. Furthermore, resection of ≥3 Couinaud liver segments [hazard ratio (HR) = 4.74; 95% confidence interval (CI), 2.32-9.67; P < 0.001], occurrence of postoperative complications (HR = 2.95; 95% CI, 1.38-6.31; P = 0.005), and early-stage postoperative ALBI grade 3 (HR = 2.50; 95% CI, 1.18-5.31; P = 0.02) were identified as independent risk factors for the OS of patients with HCC.
Early-stage postoperative ALBI grade can be used to predict the OS of patients with HCC who have undergone radical hepatectomy. Early-stage postoperative ALBI grade 3, resection of ≥3 Couinaud liver segments, and occurrence of postoperative complications are independent risk factors affecting the OS of these patients.
白蛋白-胆红素(ALBI)和 ΔALBI 分级因其能够预测肝细胞癌(HCC)患者的总生存期(OS)而受到广泛关注。本回顾性研究旨在评估 ALBI 分级在不同时间点对接受根治性切除术的 HCC 患者 OS 的预测价值。
收集我院行根治性切除术的 HCC 患者的临床资料并进行分析。采用 Kaplan-Meier 法和对数秩检验分析生存率。采用单因素和多因素 Cox 回归分析确定影响 OS 的危险因素。
本研究共纳入 104 例 HCC 患者。这些患者的 1、3 和 5 年 OS 率分别为 91.3%、64.0%和 60.2%。术后早期 ALBI 分级 2 期患者的 OS 率明显高于 3 期患者(P<0.001);而术前 ALBI 分级、晚期术后 ALBI 分级、ΔALBI 分级(早期)或 ΔALBI 分级(晚期)均不影响 OS 率。此外,切除≥3 个 Couinaud 肝段[风险比(HR)=4.74;95%置信区间(CI),2.32-9.67;P<0.001]、术后并发症的发生(HR=2.95;95%CI,1.38-6.31;P=0.005)和术后早期 ALBI 分级 3 期是影响 HCC 患者 OS 的独立危险因素(HR=2.50;95%CI,1.18-5.31;P=0.02)。
术后早期 ALBI 分级可用于预测接受根治性肝切除术的 HCC 患者的 OS。术后早期 ALBI 分级 3 期、切除≥3 个 Couinaud 肝段和术后并发症的发生是影响这些患者 OS 的独立危险因素。